Thanks for reading Bilu Huang Institute for Aging Research! Subscribe for free to receive new posts and support our work.
We are thrilled to announce a significant milestone in our journey to redefine longevity science. Prof. Jiaxuan Feng, a distinguished clinical leader from Ruijin Hospital—ranked No. 1 in Shanghai and No. 4 across China—has officially joined the Bilu Huang Aging Institute as an Independent Director.
Prof. Feng is a Chief Physician and PhD Supervisor specializing in vascular surgery, specifically focusing on age-related metabolic diseases and arteriosclerosis. As a member of the Society for Vascular Surgery (SVS) and the European Society for Vascular Surgery (ESVS), his international clinical expertise will be instrumental in bridging our core TRCS Aging Model with real-world clinical applications.
His joining marks a new chapter for Bilu Huang Aging Institute as we transition toward a "Primary-Secondary Separation" governance structure, ensuring total transparency and non-profit integrity as we pursue our mission to reverse aging.
To learn more about how Prof. Feng's clinical expertise will shape our 2026-2027 roadmap, subscribe to our newsletter below.
Thanks for reading Bilu Huang Institute for Aging Research! Subscribe for free to receive new posts and support our work.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.